These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 21784388

  • 1. Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation.
    Romaguera R, Sardi G, Laynez-Carnicero A, Ben-Dor I, Maluenda G, Wakabayashi K, Hauville C, Torguson R, Xue Z, Kent KM, Satler LF, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2011 Oct 01; 108(7):932-5. PubMed ID: 21784388
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of bivalirudin in patients receiving clopidogrel therapy after diagnostic angiography for percutaneous coronary intervention in acute coronary syndromes.
    Feldman DN, Minutello RM, Bergman G, Moussa I, Wong SC.
    Catheter Cardiovasc Interv; 2010 Oct 01; 76(4):513-24. PubMed ID: 20882655
    [Abstract] [Full Text] [Related]

  • 4. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G, Pasceri V, D'Antonio L, D'Ambrosio A, Macrì M, Dicuonzo G, Colonna G, Montinaro A, Di Sciascio G.
    Am J Cardiol; 2012 Aug 15; 110(4):478-84. PubMed ID: 22583760
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and Safety of Bivalirudin During Percutaneous Coronary Intervention in Acute Coronary Syndrome in the Real World: CARTAGOMAX Study.
    Cascón-Pérez JD, Abellán-Huerta J, Giner-Caro JA, Dau-Villareal DF, Mármol-Lozano R, Jaulent-Huertas L, Bonilla-Pacheco YI, Ruiz-Abellón Mdel C, Picó-Aracil F, Castillo-Moreno JA.
    J Cardiovasc Pharmacol; 2016 Sep 15; 68(3):248-56. PubMed ID: 27261930
    [Abstract] [Full Text] [Related]

  • 6. Safety of bivalirudin in percutaneous coronary intervention following thrombolytic therapy.
    Sardi GL, Lindsay J, Waksman R.
    Catheter Cardiovasc Interv; 2013 Oct 01; 82(4):614-20. PubMed ID: 22581418
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cardiac tamponade complicating coronary perforation during angioplasty: short-term outcomes and long-term survival.
    Stathopoulos I, Kossidas K, Panagopoulos G, Garratt K.
    J Invasive Cardiol; 2013 Oct 01; 25(10):486-91. PubMed ID: 24088420
    [Abstract] [Full Text] [Related]

  • 13. Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).
    Stone GW, Clayton T, Deliargyris EN, Prats J, Mehran R, Pocock SJ.
    J Am Coll Cardiol; 2013 Oct 01; 63(1):15-20. PubMed ID: 24140664
    [Abstract] [Full Text] [Related]

  • 14. Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database.
    Pinto DS, Ogbonnaya A, Sherman SA, Tung P, Normand SL.
    Circ Cardiovasc Qual Outcomes; 2012 Jan 01; 5(1):52-61. PubMed ID: 22235065
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bivalirudin Is Associated With Improved In-Hospital Outcomes Compared With Heparin in Percutaneous Vascular Interventions: Observational, Propensity-Matched Analysis From the Premier Hospital Database.
    Kimmelstiel C, Pinto D, Aronow HD, Weintraub AR, Dangas G, Fan W, Prats J, Deliargyris EN, Katzen BT.
    Circ Cardiovasc Interv; 2016 Jan 01; 9(1):e002823. PubMed ID: 26747849
    [Abstract] [Full Text] [Related]

  • 17. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
    Waksman R, Bertrand O, Driesman M, Gruberg L, Rossi J, Mehta S, Swymelar S, Dvir D, Xue Z, Torguson R.
    J Interv Cardiol; 2013 Apr 01; 26(2):107-13. PubMed ID: 23240743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bivalirudin in patients undergoing primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: outcomes in a large real-world population.
    Shelton R, Eftychiou C, Somers K, Liu A, Burton-Wood N, Anderson M, Makri L, Blaxill J, McLenachan J, Wheatcroft S, Greenwood J, Blackman D.
    EuroIntervention; 2013 May 20; 9(1):118-24. PubMed ID: 23410540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.